{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:41:59Z","timestamp":1763988119198},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,3,1]]},"DOI":"10.2169\/internalmedicine.5493-20","type":"journal-article","created":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T22:05:31Z","timestamp":1606082731000},"page":"783-788","source":"Crossref","is-referenced-by-count":5,"title":["Interstitial Pneumonia Secondary to Hermansky-Pudlak Syndrome Type 4 Treated with Different Antifibrotic Agents"],"prefix":"10.2169","volume":"60","author":[{"given":"Junko","family":"Itano","sequence":"first","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, National Hospital Organization Minami-Okayama Medical Center, Japan"},{"name":"Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Tanimoto","sequence":"additional","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, National Hospital Organization Minami-Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, National Hospital Organization Minami-Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, National Hospital Organization Minami-Okayama Medical Center, Japan"},{"name":"Department of Respiratory Medicine, Okayama City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisaaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, National Hospital Organization Minami-Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Ninomiya","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Kurashiki Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenjiro","family":"Kosaki","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Miyahara","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, Okayama University Graduate School of Health Sciences, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Kiura","sequence":"additional","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V14.2.162.162","volume":"14","author":"F Hermansky","year":"1959","unstructured":"1. Hermansky F, Pudlak P. Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies. Blood 14: 162-169, 1959.","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Souheil El, Young LR. Hermansky-Pudlak Syndrome. Clin Chest Med 37: 505-511, 2016.","DOI":"10.1016\/j.ccm.2016.04.012"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Vicary GW, Vergne Y, Santiago-Cornier A, Young L, Roman J. Pulmonary fibrosis in Hermansky-Pudlak syndrome. Ann Am Thorac Soc 10: 1839-1846, 2016.","DOI":"10.1513\/AnnalsATS.201603-186FR"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gahl WA, Brantly M, Troendle J, et al. Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome. Genet Metab 76: 234-242, 2002.","DOI":"10.1016\/S1096-7192(02)00044-6"},{"key":"5","unstructured":"5. Raghu G, Rochwerg B, Zhang Y, et al. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med 192: e3-e19, 2015."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Flaherty KR, Wells AU, Cottin V, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381: 1718-1727, 2019.","DOI":"10.1056\/NEJMoa1908681"},{"key":"7","unstructured":"7. Gagnier JJ, Kienle G, Altman DG, et al. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 67: 46-51, 2014."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Taniguchi H, Ebina M, Kondoh Y, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 35: 821-829, 2010.","DOI":"10.1183\/09031936.00005209"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Seward SL, Gahl WA. Hermansky-Pudlak syndrome: health care throughout life. Pediatrics 132: 153-160, 2013.","DOI":"10.1542\/peds.2012-4003"},{"key":"10","unstructured":"10. Anderson PD, Huizing M, Claassen DA, et al. Gahl Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics. Hum Genet 113: 10-17, 2003."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lederer DJ, Kawut SM, Sonett JR, et al. Successful bilateral lung transplantation for pulmonary fibrosis associated with Hermansky-Pudlak syndrome. J Heart Lung Transplant 24: 1697-1699, 2005.","DOI":"10.1016\/j.healun.2004.11.015"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Pierson DM, Ionescu D, Qing G, et al. Pulmonary fibrosis in Hermansky-Pudlak syndrome. Respiration 73: 382-395, 2006.","DOI":"10.1159\/000091609"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. O&apos;Brien K, Troendle J, Gochuico BR, et al. Pirfenidone for the treatment of Hermansky-Pudlak syndrome pulmonary fibrosis. Mol Genet Metab 103: 128-134, 2011.","DOI":"10.1016\/j.ymgme.2011.02.003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chiang PW, Oiso N, Gautam R, Suzuki T, Swank RT, Spritz RA. The Hermansky-Pudlak syndrome 1 (HPS1) and HPS4 proteins are components of two complexes, BLOC-3 and BLOC-4, involved in the biogenesis of lysosome-related organelles. J Biol Chem 278: 20332-20337, 2003.","DOI":"10.1074\/jbc.M300090200"},{"key":"15","unstructured":"15. Nakatani Y, Nakamura N, Sano J, et al. Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling\/degeneration (giant lamellar body degeneration) of type-2 pneumocytes. Virchows Arch 437: 304-313, 2000."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. G\u00fcnther A, Korfei M, Mahavadi P, von der Beck D, Ruppert C, Markart P. Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis. Eur Respir Rev 21: 152-160, 2012.","DOI":"10.1183\/09059180.00001012"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sakata Y, Kawamura K, Ichikado K, et al. Hermansky-Pudlak syndrome type 4 with interstitial pneumonia. Respir Med Case Rep 9: 38-41, 2013.","DOI":"10.1016\/j.rmcr.2013.04.002"},{"key":"18","unstructured":"18. Hilberg F, Roth GJ, Krssak M, et al. BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res 68: 4774-4782, 2008."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wollin L, Wex E, Pautsch A, et al. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis. Eur Respir J 45: 1434-1445, 2015.","DOI":"10.1183\/09031936.00174914"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Distler O, Highland KB, Gahlemann M, et al. Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med 380: 2518-2528, 2019.","DOI":"10.1056\/NEJMoa1903076"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/5\/60_5493-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T03:58:43Z","timestamp":1615003123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/5\/60_5493-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5493-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}